CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2017 Financial Results Genetics Investing
Sunesis Pharmaceuticals Reports Fourth Quarter and Full-Year 2017 Financial Results and Recent Highlights Pharmaceutical Investing
Fibrocell Announces FDA Allowance of Investigational New Drug Application for FCX-013 Genetics Investing
Cellular Biomedicine Group Reports Full-Year 2017 Financial Results and Recent Operational Progress Genetics Investing
3D Signatures and l’Institut Universitaire de Cardiologie et de Pneumologie de Québec Announce Collaboration Genetics Investing